Parameter
| Biomarker | VEGF-A | Full name | Vascular endothelial growth factor A | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | 45 kDa | Core Functional Dimensions | Therapeutic targets, prognosis | |
| Disease | Angiosarcoma | Disease Subtypes | / | ||
| Organ | Tumor cells, macrophages, endothelial cells | Test Sample / Technology Platform | Tissue/serum (IHC, ELISA) | ||
| Pathobiological Mechanisms | Promote vascular endothelial cell proliferation, migration and vascular permeability increase | ||||
| Clinical Availability Status | Clinical validation/therapeutic targets: VEGF inhibitors targets | ||||
| Notes and Dynamics | 86% (85% 94%) AS expression, serum level and positively related to the tumor stage | ||||